Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v2.4.0.8
Consolidated Statements of Operations (USD $)
 3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Revenues        
Products $ 1,094,529 $ 779,455 $ 5,047,231 $ 3,639,974
Services 3,081,334 2,113,785 7,884,246 6,103,044
Total revenues 4,175,863 2,893,240 12,931,477 9,743,018
Cost of sales        
Products 1,052,199 571,803 4,043,783 2,793,743
Services 2,034,193 1,228,805 5,023,324 3,930,806
Cost of Goods and Services Sold 3,086,392 1,800,608 9,067,107 6,724,549
Gross Profit 1,089,471 1,092,632 3,864,370 3,018,469
Operating expenses        
General and administrative 1,751,080 1,437,068 5,424,143 4,358,569
Aborted public offering costs   320,924   320,924
Research and Development Expense 329,524 260,262 889,240 809,746
Selling 476,601 488,895 1,303,329 1,054,366
Selling, General and Administrative Expense 2,557,205 2,507,149 7,616,712 6,543,605
Operating Income (Loss) (1,467,734) (1,414,517) (3,752,342) (3,525,136)
Other income (expense)        
Interest and other income 17,763 7,256 35,927 13,793
Interest expense (30,666) (45,072) (122,818) (104,836)
Interest Income (Expense), Net (12,903) (37,816) (86,891) (91,043)
Consolidated net loss (1,480,637) (1,452,333) (3,839,233) (3,616,179)
Less: Loss attributable to the noncontrolling interest 32,839 64,654 123,683 277,627
Net loss attributable to Tecogen Inc. $ (1,447,798) $ (1,387,679) $ (3,715,550) $ (3,338,552)
Net loss per share - basic and diluted $ (0.09) $ (0.11) $ (0.25) $ (0.25)
Weighted average shares outstanding - basic and diluted 15,447,726 13,212,894 15,160,041 13,212,894